[
International C. elegans Meeting,
2001]
A significant portion of mutations in Caenorhabditis elegans genes cause lethality. To study late effects of a lethal mutant, an inducible promotor system is desireable. In addition, ectopic expression of a candidate gene is a useful way to learn about the (mis-)function of a gene. Ectopic expression in C. elegans can be achieved by using a heat shock inducible promotor or by using different endogenous promotors. However for most of these promotors the time of expression and the expression level cannot be controlled. In contrast, inducible promotor systems based on chimeric transcription factors have been widely used to regulate gene expression in many different eukaryotic systems (e.g. insects, mice, yeast and plants). In order to test the efficiency of the tetracycline (Tc) responsive regulatory system in C. elegans we generated lines expressing the tetracycline-controlled transactivator proteins (tTA2/rtTA2). These proteins bind to DNA and therefore activate transcription in the presence (rtTA2) or absence (tTA2) of the antibiotics tetracycline or doxycycline (a more potent tetracycline agonist). We have crossed these lines with lines containing a tTA2/rtTA2 responsive promotor fused to a reporter gene and showed that gene expression could be induced (rtTA2) or inhibited (tTA2) by doxycycline treatment. We are constructing different promotor-transactivator fusions to test the ability of this system to direct gene expression in specific cells.